Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Skye Bioscience Appoints New Chief Financial Officer Following Resignation
PUBLIC · SKYESep 11, 2026•about 10 hours ago
Position
Chief Financial Officer
Company
Skye Bioscience
San DiegoBiotechnologyHealthcareDescription
On September 8, 2026, Skye Bioscience, Inc. announced the resignation of John P. Sharp from his role as Chief Financial Officer
Don't miss Skye Bioscience's next move
Get an email the moment Skye Bioscience changes its leadership, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months
Skye Bioscience changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.